These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16412477)

  • 1. Orange juice increased the bioavailability of pravastatin, 3-hydroxy-3-methylglutaryl CoA reductase inhibitor, in rats and healthy human subjects.
    Koitabashi Y; Kumai T; Matsumoto N; Watanabe M; Sekine S; Yanagida Y; Kobayashi S
    Life Sci; 2006 May; 78(24):2852-9. PubMed ID: 16412477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin.
    Lilja JJ; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 1999 Aug; 66(2):118-27. PubMed ID: 10460065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone interacts with simvastatin but not with pravastatin disposition kinetics.
    Becquemont L; Neuvonen M; Verstuyft C; Jaillon P; Letierce A; Neuvonen PJ; Funck-Brentano C
    Clin Pharmacol Ther; 2007 May; 81(5):679-84. PubMed ID: 17301736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.
    Neuvonen PJ; Kantola T; Kivistö KT
    Clin Pharmacol Ther; 1998 Mar; 63(3):332-41. PubMed ID: 9542477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pravastatin, an HMG-CoA reductase inhibitor, is transported by rat organic anion transporting polypeptide, oatp2.
    Tokui T; Nakai D; Nakagomi R; Yawo H; Abe T; Sugiyama Y
    Pharm Res; 1999 Jun; 16(6):904-8. PubMed ID: 10397612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grapefruit juice-simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors.
    Lilja JJ; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 1998 Nov; 64(5):477-83. PubMed ID: 9834039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin.
    Niemi M; Pasanen MK; Neuvonen PJ
    Clin Pharmacol Ther; 2006 Oct; 80(4):356-66. PubMed ID: 17015053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin.
    Lilja JJ; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 2000 Oct; 68(4):384-90. PubMed ID: 11061578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orange juice and its component, hesperidin, decrease the expression of multidrug resistance-associated protein 2 in rat small intestine and liver.
    Watanabe M; Matsumoto N; Takeba Y; Kumai T; Tanaka M; Tatsunami S; Takenoshita-Nakaya S; Harimoto Y; Kinoshita Y; Kobayashi S
    J Biomed Biotechnol; 2011; 2011():502057. PubMed ID: 21660137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orange juice substantially reduces the bioavailability of the beta-adrenergic-blocking agent celiprolol.
    Lilja JJ; Juntti-Patinen L; Neuvonen PJ
    Clin Pharmacol Ther; 2004 Mar; 75(3):184-90. PubMed ID: 15001969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of organic anion transporting polypeptide 1B1 haplotype on pharmacokinetics of pravastatin, valsartan, and temocapril.
    Maeda K; Ieiri I; Yasuda K; Fujino A; Fujiwara H; Otsubo K; Hirano M; Watanabe T; Kitamura Y; Kusuhara H; Sugiyama Y
    Clin Pharmacol Ther; 2006 May; 79(5):427-39. PubMed ID: 16678545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Lemon and Seville Orange Juices on the Pharmacokinetic Properties of Sildenafil in Healthy Subjects.
    Abdelkawy KS; Donia AM; Turner RB; Elbarbry F
    Drugs R D; 2016 Sep; 16(3):271-278. PubMed ID: 27550653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters.
    Hsiang B; Zhu Y; Wang Z; Wu Y; Sasseville V; Yang WP; Kirchgessner TG
    J Biol Chem; 1999 Dec; 274(52):37161-8. PubMed ID: 10601278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal drug transporter expression and the impact of grapefruit juice in humans.
    Glaeser H; Bailey DG; Dresser GK; Gregor JC; Schwarz UI; McGrath JS; Jolicoeur E; Lee W; Leake BF; Tirona RG; Kim RB
    Clin Pharmacol Ther; 2007 Mar; 81(3):362-70. PubMed ID: 17215845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of regular consumption of grapefruit juice on the pharmacokinetics of simvastatin.
    Lilja JJ; Neuvonen M; Neuvonen PJ
    Br J Clin Pharmacol; 2004 Jul; 58(1):56-60. PubMed ID: 15206993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of the ABCG2 c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin.
    Keskitalo JE; Pasanen MK; Neuvonen PJ; Niemi M
    Pharmacogenomics; 2009 Oct; 10(10):1617-24. PubMed ID: 19842935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine.
    Dresser GK; Bailey DG; Leake BF; Schwarz UI; Dawson PA; Freeman DJ; Kim RB
    Clin Pharmacol Ther; 2002 Jan; 71(1):11-20. PubMed ID: 11823753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors.
    Jacobson TA
    Am J Cardiol; 2004 Nov; 94(9):1140-6. PubMed ID: 15518608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics.
    Nishizato Y; Ieiri I; Suzuki H; Kimura M; Kawabata K; Hirota T; Takane H; Irie S; Kusuhara H; Urasaki Y; Urae A; Higuchi S; Otsubo K; Sugiyama Y
    Clin Pharmacol Ther; 2003 Jun; 73(6):554-65. PubMed ID: 12811365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of multiple transporters in the efflux of 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors across the blood-brain barrier.
    Kikuchi R; Kusuhara H; Abe T; Endou H; Sugiyama Y
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1147-53. PubMed ID: 15292460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.